Andreas G. Beringer

Emil Barell Str. 1
Grenzach-wyhlen, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

Baseline mutational profiles of patients with carcinoma of unknown primary origin enrolled in the CUPISCO study.

Journal: ESMO open

Published: March 02, 2023

Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.

Cancer-of-Unknown-Primary-Origin: A SEER-Medicare Study of Patterns of Care and Outcomes among Elderly Patients in Clinical Practice.

Journal: Cancers

Published: April 21, 2022

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

A Challenging Task: Identifying Patients with Cancer of Unknown Primary (CUP) According to ESMO Guidelines: The CUPISCO Trial Experience.

Journal: The oncologist

Published: October 23, 2020

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.

Comprehensive Genomic Profiling of Carcinoma of Unknown Primary Origin: Retrospective Molecular Classification Considering the CUPISCO Study Design.

Journal: The oncologist

Published: July 22, 2020

Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial

Erlotinib plus Gemcitabine in metastatic pancreatic cancer: Results from a non-interventional trial

Journal: Zeitschrift fur Gastroenterologie

Published: February 14, 2020

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study.

Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib - results from a non-interventional multi-center study.

Journal: BMC cancer

Published: May 19, 2019

Polyamide/PEG Blends as Biocompatible Biomaterials for the Convenient Regulation of Cell Adhesion and Growth.

Polyamide/PEG Blends as Biocompatible Biomaterials for the Convenient Regulation of Cell Adhesion and Growth.

Journal: Macromolecular rapid communications

Published: February 25, 2019

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).

Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07).

Journal: Neuro-oncology

Published: October 11, 2017

Piezosurgery in Modified Pterional Orbital Decompression Surgery in Graves Disease.

Piezosurgery in Modified Pterional Orbital Decompression Surgery in Graves Disease.

Journal: World neurosurgery

Published: March 29, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026